OMI is shedding its old skin with that $375M segment sale – smart move! 📉 The stock's been beaten down with RSI screaming oversold (below 30!), but this strategic pivot could be the catalyst. The chart shows a potential bottom forming after that nasty slide. This looks like a classic "bad news is priced in" setup. I'm calling it a contrarian BUY for a turnaround play. #DeepValue

"OMI just dropped Q2 earnings with mixed vibes—some love for healthcare innovations, but Wall Street’s still side-eyeing the transformation pain. 📉 Technically? Oof. That 9-period WMA nosedived below the 21, and RSI is flirting with oversold (26.7—yikes). Volume spiked on the sell-off, and the chart looks like a rollercoaster after bad news. Until the dust settles, this feels like a HOLD (or a brave contrarian’s dip-buy). #HealthcareHustle"